Skip to main content
SpringerLink
Log in

Current status of contrast-induced nephropathy and nephrogenic systemic fibrosis in children

  • Review
  • Published:
Pediatric Radiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rigsby CK, Eric Gasber E, Seshadri R et al (2007) safety and efficacy of pressure-limited power injection of iodinated contrast medium through central lines in children. AJR 188:726–732

    Article  PubMed  Google Scholar 

  2. Oguz B, Haliloglu M, Karcaaltincaba M (2007) Paediatric multidetector CT angiography: spectrum of congenital thoracic vascular anomalies. Br J Radiol 80:376–383

    Article  PubMed  CAS  Google Scholar 

  3. Frush DP (2008) Pediatric abdominal CT angiography. Pediatr Radiol 38(Suppl 2):S259–S266

    Article  PubMed  Google Scholar 

  4. Brasch RC (2008) Contrast media toxicity in children. Pediatr Radiol 38(Suppl 2):S281–S284

    Article  PubMed  Google Scholar 

  5. Fitoz S, Unsal N, Tekin M et al (2007) Contrast-enhanced MR angiography of thoracic vascular malformations in children. Int J Cardiol 123:3–11

    Article  PubMed  Google Scholar 

  6. Herts BR, Schineider E, Poggio ED et al (2008) Identifying outpatients with renal insufficiency before contrast-enhanced CT by using estimated glomerular filtration rates versus serum creatinine levels. Radiology 248:106–113

    Article  PubMed  Google Scholar 

  7. Halvorsen RA (2008) Which study when? Iodinated contrast-enhanced CT versus gadolinium-enhanced MR imaging. Radiology 249:9–15

    Article  PubMed  Google Scholar 

  8. Weinreb JC (2008) Which study when? Is gadolinium-enhanced MR imaging safer than iodine-enhanced CT? Radiology 249:3–8

    Article  PubMed  Google Scholar 

  9. Thomsen HS (2007) Current evidence on prevention and management of contrast-induced nephropathy. Eur Radiol 17(Suppl 6):F33–F37

    PubMed  Google Scholar 

  10. Cohen M (2008) What is the normal serum creatinine concentration in children? Pediatr Radiol 38:1265

    Article  PubMed  Google Scholar 

  11. Bessell-Browne R, O'Malley ME (2007) CT of pheochromocytoma and paraganglioma: risk of adverse events with i.v. administration of nonionic contrast material. AJR 188:970–974

    Google Scholar 

  12. Prince MR, Erel HE, Lent RW et al (2003) Gadodiamide administration causes spurious hypocalcemia. Radiology 227:639–646

    Article  PubMed  Google Scholar 

  13. Emerson J, Kost G (2004) Spurious hypocalcemia after Omniscan- or OptiMARK-enhanced magnetic resonance imaging: an algorithm for minimizing a false-positive laboratory value. Arch Pathol Lab Med 128:1151–1156

    PubMed  CAS  Google Scholar 

  14. Haage P, Schmitz-Rode T, Hübner D et al (2000) Reduction of contrast material dose and artifacts by a saline flush using a double power injector in helical CT of the thorax. AJR 174:1049–1053

    PubMed  CAS  Google Scholar 

  15. Dorio PJ, Lee FT Jr, Henseler KP et al (2003) Using a saline chaser to decrease contrast media in abdominal CT. AJR 180:929–934

    PubMed  Google Scholar 

  16. Karcaaltincaba M, Foley D (2005) Four- and eight-channel aortoiliac CT angiography: a comparative study. Cardiovasc Intervent Radiol 28:169–172

    Article  PubMed  Google Scholar 

  17. Karcaaltincaba M, Aydingoz U, Akata D et al (2004) Combination of extremity computed tomography angiography and abdominal imaging in patients with musculoskeletal tumors. J Comput Assist Tomogr 28:273–277

    Article  PubMed  Google Scholar 

  18. Juluru K, Vogel-Claussen J, Macura KJ et al (2009) MR imaging in patients at risk for developing nephrogenic systemic fibrosis: protocols, practices, and imaging techniques to maximize patient safety. Radiographics 29:9–22

    Article  PubMed  Google Scholar 

  19. Nural MS, Gokce E, Danaci M et al (2008) Focal liver lesions: whether a standard dose (0.05 mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1 mmol/kg dose. Eur J Radiol 66:65–74

    Article  PubMed  Google Scholar 

  20. Elicker BM, Cypel YS, Weinreb JC (2006) IV contrast administration for CT: a survey of practices for the screening and prevention of contrast nephropathy. AJR 186:1651–1658

    Article  PubMed  Google Scholar 

  21. Brezis M, Rosen S (1995) Hypoxia of the renal medulla—its implications for disease. N Engl J Med 332:647–655

    Article  PubMed  CAS  Google Scholar 

  22. Newhouse JH, Kho D, Rao QA et al (2008) Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR 191:376–382

    Article  PubMed  Google Scholar 

  23. Bruce RJ, Djamali A, Shinki K et al (2009) Background fluctuation of kidney function versus contrast-induced nephrotoxicity. AJR 192:711–718

    Article  PubMed  Google Scholar 

  24. Morcos SK, Bellin MF, Thomsen HS et al (2008) Reducing the risk of iodine-based and MRI contrast media administration: recommendation for a questionnaire at the time of booking. Eur J Radiol 66:225–229

    Article  PubMed  Google Scholar 

  25. Perez-Rodriguez J, Lai S, Ehst BD et al (2009) Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment—report of 33 cases. Radiology 250:371–377

    Article  PubMed  Google Scholar 

  26. Cowper SE, Robin HS, Steinberg SM et al (2000) Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 356:1000–1001

    Article  PubMed  CAS  Google Scholar 

  27. Grobner T (2006) Gadolinium—a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21:1104–1108

    Article  PubMed  CAS  Google Scholar 

  28. Marckmann P, Skov L, Rossen K et al (2006) Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 17:2359–2362

    Article  PubMed  Google Scholar 

  29. Thomsen HS, Marckmann P (2008) Extracellular Gd-CA: differences in prevalence of NSF. Eur J Radiol 66:180–183

    Article  PubMed  Google Scholar 

  30. Prince MR, Zhang H, Morris M et al (2008) Incidence of nephrogenic systemic fibrosis at two large medical centers. Radiology 248:807–816

    Article  PubMed  Google Scholar 

  31. Wiginton CD, Kelly B, Oto A et al (2008) Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue. AJR 190:1060–1068

    Article  PubMed  Google Scholar 

  32. Aydingoz U (2006) The need for radiologists’ awareness of nephrogenic systemic fibrosis. Diagn Interv Radiol 12:161–162

    PubMed  Google Scholar 

  33. Wertman R, Altun E, Martin DR et al (2008) Risk of nephrogenic systemic fibrosis: evaluation of gadolinium chelate contrast agents at four American universities. Radiology 248:799–806

    Article  PubMed  Google Scholar 

  34. Sadowski EA, Bennett LK, Chan MR et al (2007) Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 243:148–157

    Article  PubMed  Google Scholar 

  35. Martin DR (2008) Nephrogenic systemic fibrosis. Pediatr Radiol 38(Suppl 1):S125–S129

    Article  PubMed  Google Scholar 

  36. Jain SM, Wesson S, Hassanein A et al (2004) Nephrogenic fibrosing dermopathy in pediatric patients. Pediatr Nephrol 19:467–470

    Article  PubMed  Google Scholar 

  37. Dharnidharka VR, Wesson SK, Fennell RS (2007) Gadolinium and nephrogenic fibrosing dermopathy in pediatric patients. Pediatr Nephrol 22:1395

    Article  PubMed  Google Scholar 

  38. Kadiyala D, Roer DA, Perazella MA (2009) Nephrogenic systemic fibrosis associated with gadoversetamide exposure: treatment with sodium thiosulfate. Am J Kidney Dis 53:133–137

    Article  PubMed  Google Scholar 

  39. Kreuter A, Gambichler T, Weiner SM et al (2008) Limited effects of UV-A1 phototherapy in 3 patients with nephrogenic systemic fibrosis. Arch Dermatol 144:1527–1529

    Article  PubMed  Google Scholar 

  40. Chandran S, Petersen J, Jacobs C et al (2009) Imatinib in the treatment of nephrogenic systemic fibrosis. Am J Kidney Dis 53:129–132

    Article  PubMed  Google Scholar 

  41. Panesar M, Banerjee S, Barone GW (2008) Clinical improvement of nephrogenic systemic fibrosis after kidney transplantation. Clin Transplant 22:803–808

    PubMed  Google Scholar 

  42. Kay J, High WA (2008) Imatinib mesylate treatment of nephrogenic systemic fibrosis. Arthritis Rheum 58:2543–2548

    Article  PubMed  CAS  Google Scholar 

  43. Duffy KL, Green L, Harris R et al (2008) Treatment of nephrogenic systemic fibrosis with Re-PUVA. J Am Acad Dermatol 59(2 Suppl 1):S39–S40

    Article  PubMed  Google Scholar 

  44. Karcaaltincaba M, Foley WD (2002) Gadolinium-enhanced multidetector CT angiography of the thoracoabdominal aorta. J Comput Assist Tomogr 26:875–878

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Hacettepe University School of Medicine, Ankara, 06100, Turkey

    Musturay Karcaaltincaba, Berna Oguz & Mithat Haliloglu

Authors
  1. Musturay Karcaaltincaba
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Berna Oguz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mithat Haliloglu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Musturay Karcaaltincaba.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karcaaltincaba, M., Oguz, B. & Haliloglu, M. Current status of contrast-induced nephropathy and nephrogenic systemic fibrosis in children. Pediatr Radiol 39 (Suppl 3), 382–384 (2009). https://doi.org/10.1007/s00247-009-1236-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00247-009-1236-3

Search

Navigation